Platinum Investment Management LTD Inhibrx, Inc. Transaction History

Platinum Investment Management LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$32.76 - $39.56 $714,069 - $862,289	-21,797 Reduced 12.99%	145,966 $5.1 Million
Q4 2023 Feb 13, 2024	SELL	$14.5 - $38.0 $888,458 - $2.33 Million	-61,273 Reduced 26.75%	167,763 $6.37 Million
Q2 2023 Aug 10, 2023	BUY	$16.96 - $27.82 $115,785 - $189,927	6,827 Added 3.07%	229,036 $5.95 Million
Q1 2023 May 11, 2023	BUY	$18.45 - $27.14 $1.15 Million - $1.68 Million	62,082 Added 38.77%	222,209 $4.19 Million
Q4 2022 Feb 13, 2023	BUY	$20.18 - $33.33 $280,845 - $463,853	13,917 Added 9.52%	160,127 $3.95 Million
Q3 2022 Nov 14, 2022	SELL	$11.58 - $24.73 $160,834 - $343,474	-13,889 Reduced 8.68%	146,210 $2.62 Million
Q2 2022 Aug 11, 2022	BUY	$8.52 - $25.26 $623,408 - $1.85 Million	73,170 Added 84.17%	160,099 $1.82 Million
Q4 2021 Feb 11, 2022	SELL	$26.75 - $46.02 $445,494 - $766,417	-16,654 Reduced 16.08%	86,929 $3.8 Million
Q3 2021 Nov 09, 2021	SELL	$25.18 - $37.81 $1.3 Million - $1.96 Million	-51,818 Reduced 33.34%	103,583 $3.45 Million
Q1 2021 May 13, 2021	BUY	$16.27 - $41.26 $1.55 Million - $3.93 Million	95,296 Added 158.55%	155,401 $3.12 Million
Q4 2020 Feb 12, 2021	SELL	$15.96 - $50.0 $237,724 - $744,750	-14,895 Reduced 19.86%	60,105 $1.98 Million
Q3 2020 Nov 13, 2020	BUY	$16.77 - $20.65 $1.26 Million - $1.55 Million	75,000 New	75,000 $1.35 Million

18.6K

Ticker INBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,057,700
Market Cap $570M
Description
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.